More
A new report from 3A Business Consulting, “Global Opportunities for Whey and Lactose Ingredients 2010-2014,” documents how whey and lactose ingredients continue to show positive growth rates in volume terms and less so in value terms.
A new report from 3A Business Consulting, “Global Opportunities for Whey and Lactose Ingredients 2010-2014,” documents how whey and lactose ingredients continue to show positive growth rates in volume terms and less so in value terms.
“The extreme price increases in 2006 and first half of 2007 forced many food manufacturers to replace expensive whey and lactose ingredients with cheaper food ingredients, resulting in less demand for products. However, demand has been re-established at previous levels in 2010, assisted by lower prices and recovery of the global economy,” says Tage Affertsholt, managing partner.
Whey powder, whey proteins and whey protein fractions represent a global market value of approximately $5 billion in 2010 and are forecast to be about $6.4 billion in 2014 (a compound annual growth rate of 4% at constant prices). Lactose, pharmaceutical lactose, permeate and lactose derivatives are worth more than $1.6 billion in 2010 and are estimated to be nearly $2 billion in 2014, according to 3A Business Consulting, Aarhus, Denmark. The full report is available for purchase.
3A Business Consulting
011 +45 70 21 00 98
www.3abc.dk
A new report from 3A Business Consulting, “Global Opportunities for Whey and Lactose Ingredients 2010-2014,” documents how whey and lactose ingredients continue to show positive growth rates in volume terms and less so in value terms.
“The extreme price increases in 2006 and first half of 2007 forced many food manufacturers to replace expensive whey and lactose ingredients with cheaper food ingredients, resulting in less demand for products. However, demand has been re-established at previous levels in 2010, assisted by lower prices and recovery of the global economy,” says Tage Affertsholt, managing partner.
Whey powder, whey proteins and whey protein fractions represent a global market value of approximately $5 billion in 2010 and are forecast to be about $6.4 billion in 2014 (a compound annual growth rate of 4% at constant prices). Lactose, pharmaceutical lactose, permeate and lactose derivatives are worth more than $1.6 billion in 2010 and are estimated to be nearly $2 billion in 2014, according to 3A Business Consulting, Aarhus, Denmark. The full report is available for purchase.
3A Business Consulting
011 +45 70 21 00 98
www.3abc.dk
With access to over one million professionals and more than 60 industry-specific publications,
